Recommended Topic Related To:

Alrex

" Allergy medications overview

The arsenal of allergy drugs includes dozens of medications that relieve allergy symptoms when confronted with a trigger known as an allergen. That trigger could be something from a plant, such as polle"...

Alrex

Alrex

Alrex Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Alrex (loteprednol etabonate ophthalmic suspension) is used to treat eye swelling caused by surgery, infection, allergies, and other conditions. It is a corticosteroid. Common side effects include minor burning when using the eye drops, dry, red, itchy, or watery eyes, feeling that something is in the eye, sensitivity to light, headache, runny nose, or sore throat.

The dose of Alrex is one drop instilled into the affected eye(s) four times daily. It is not likely other drugs you take orally or inject will interact with Alrex used in the eyes. But many drugs can interact with each other. Tell your doctor all medications and supplements you use. During pregnancy, Alrex should be taken only if prescribed. It is unknown if it will harm a fetus. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.

Our Alrex (loteprednol etabonate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Patient Information in Detail?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Alrex in Detail - Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using loteprednol and call your doctor at once if you have any of these serious side effects:

  • signs of a new eye infection such as swelling, redness, irritation, or drainage;
  • problems with your vision; or
  • severe pain, burning or stinging when using the eye drops.

Less serious side effects may include:

  • minor burning when using the eye drops;
  • dry, red, itchy, or watery eyes;
  • feeling that something is in your eye;
  • being more sensitive to light;
  • headache; or
  • runny nose, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Alrex (Loteprednol Etabonate Ophthalmic Suspension) »

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Alrex FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.

Ocular adverse reactions occurring in 5-15% of patients treated with loteprednol etabonate ophthalmic suspension (0.2% - 0.5%) in clinical studies included abnormal vision/blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia. Other ocular adverse reactions occurring in less than 5% of patients include conjunctivitis, corneal abnormalities, eyelid erythema, keratoconjunctivitis, ocular irritation/pain/discomfort, papillae, and uveitis. Some of these events were similar to the underlying ocular disease being studied.

Non-ocular adverse reactions occurred in less than 15% of patients. These include headache, rhinitis and pharyngitis.

In a summation of controlled, randomized studies of individuals treated for 28 days or longer with loteprednol etabonate, the incidence of significant elevation of intraocular pressure ( ≥ 10 mm Hg) was 2% (15/901) among patients receiving loteprednol etabonate, 7% (11/164) among patients receiving 1% prednisolone acetate and 0.5% (3/583) among patients receiving placebo. Among the smaller group of patients who were studied with ALREX, the incidence of clinically significant increases in IOP ( ≥ 10 mm Hg) was 1% (1/133) with ALREX and 1% (1/135) with placebo.

Read the entire FDA prescribing information for Alrex (Loteprednol Etabonate Ophthalmic Suspension) »

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.

advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations